---
title: Post-Transplant Lymphoproliferative Disorders (Review for Seminars in Nephrology)
date: '2024-03-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38519279/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240323180616&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Post-transplant lymphoproliferative disorders (PTLDs) are a heterogenous
  set of unregulated lymphoid cell proliferations after organ or tissue transplant.
  A majority of cases are associated with the Epstein-Barr virus and higher intensity
  of pharmacologic immunosuppression. The clinical presentations are numerous. The
  diagnosis is ideally by histology, except in cases where the tumor is inaccessible
  to biopsy. While some pre-emptive therapies and treatment strategies are available
  ...
disable_comments: true
---
Post-transplant lymphoproliferative disorders (PTLDs) are a heterogenous set of unregulated lymphoid cell proliferations after organ or tissue transplant. A majority of cases are associated with the Epstein-Barr virus and higher intensity of pharmacologic immunosuppression. The clinical presentations are numerous. The diagnosis is ideally by histology, except in cases where the tumor is inaccessible to biopsy. While some pre-emptive therapies and treatment strategies are available ...